CVE-2026-54216: Tobit Laboratories AG TeamDavid's Webbox application contains a reflected cross-site scripting (XSS)
Source GCVE Database
Not known to be exploited · CVSS 5.3 Medium : upgrade to Rollout 528 when convenient.
Data as of 26 Oct 2026, 13:47 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in Rollout 528
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 7 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Upgrade TeamDavid to Rollout 528.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Tobit Laboratories AGTeamDavid | Affected
| Fixed in
|
Description
Tobit Laboratories AG TeamDavid's Webbox application contains a reflected cross-site scripting (XSS) vulnerability. By sending a specially crafted link including an arbitrary path, an XSS payload or the parameter “EntryInfo”, and the parameter “!templateName=entryMail”, an attacker can cause the payload to execute in the victim’s browser when they click the link. This issue affects TeamDavid through Rollout 524.